Labs / ADME, DMPK & toxicology

Canthera Discovery
Melbourne, Australia · cantheradiscovery.com
Canthera Discovery is an oncology-focused small molecule drug discovery and development organisation based in Melbourne, Victoria, Australia. It partners with research institutes, universities, and biotechnology companies to advance cancer research into therapeutic outcomes and clinical candidates.
They take quote requests by email.
What they offer
Recombinant protein production
Produces recombinant proteins to support drug discovery projects.
Collaborative partnerships
Works with industry and research partners on drug discovery and development projects.
Translational cancer biology
Applies cancer biology expertise to move research toward therapeutic outcomes.
Drug metabolism and pharmacokinetics
Supports DMPK studies as part of the discovery and development platform.
High throughput screening
Screens compounds to identify small molecule hits.
Medicinal chemistry
Designs and optimizes small molecule compounds for lead discovery and development.
e-Research Technologies
Uses digital research technologies to support discovery and development work.
Structural biology
Applies structural biology methods to support target and drug discovery work.
What they work on
- Modalities
- Small molecule, Recombinant protein
- Assays and studies
- high throughput screening
- Therapeutic areas
- oncology, cancer
- Sites
- Melbourne, Australia
- Serves
- Australia
- Address
- 305 Grattan Street Melbourne Victoria 3000
- Founded
- 2007
Similar labs. Sai Life, Venenum Biodesign, Aurigene Pharmaceutical Services, HitGen
Found in a contract services directory. Listing built from cantheradiscovery.com. Work here? Claim this listing.